Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.

Elias, D; Vever, H; Lænkholm, A-V; Gjerstorff, M F; Yde, C W; Lykkesfeldt, A E; Ditzel, H J

Elias, D; Vever, H; Lænkholm, A-V; Gjerstorff, M F; Yde, C W; Lykkesfeldt, A E; Ditzel, H J.

Afiliación

Elias D; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, Denmark. delias@health.sdu.dk.
Vever H; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, Denmark.
Lænkholm AV; Department of Pathology, Slagelse Hospital, Slagelse, Denmark.
Gjerstorff MF; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, Denmark.
Yde CW; Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark.
Lykkesfeldt AE; Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark.
Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, Denmark. hditzel@health.sdu.dk.

Oncogene ; 37(41): 5585-5586, 2018 10.

Article en En | MEDLINE | ID: mdl-30242243

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google